These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26552464)

  • 1. Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia.
    Lee HJ; Kim DH; Lee S; Koh MS; Kim SY; Lee JH; Lee S; Oh SY; Han JY; Kim HJ; Kim SH
    Korean J Intern Med; 2015 Nov; 30(6):884-90. PubMed ID: 26552464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of overt disseminated intravascular coagulation: a comparative study using criteria from the International Society versus the Korean Society on Thrombosis and Hemostasis.
    Lee JH; Song JW; Song KS
    Yonsei Med J; 2007 Aug; 48(4):595-600. PubMed ID: 17722230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation ≥ 6: a new predictor of hemorrhagic early death in acute promyelocytic leukemia.
    Mitrovic M; Suvajdzic N; Bogdanovic A; Kurtovic NK; Sretenovic A; Elezovic I; Tomin D
    Med Oncol; 2013 Mar; 30(1):478. PubMed ID: 23371042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia.
    Shahmarvand N; Oak JS; Cascio MJ; Alcasid M; Goodman E; Medeiros BC; Arber DA; Zehnder JL; Ohgami RS
    Int J Lab Hematol; 2017 Aug; 39(4):375-383. PubMed ID: 28422420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Performance Evaluation of the International Society on Thrombosis and Hemostasis and the Korean Society on Thrombosis and Hemostasis Scores in the Early Phase of Trauma.
    Kim HS; Lee DH; Lee BK; Cho YS
    J Korean Med Sci; 2018 Jan; 33(3):e21. PubMed ID: 29215808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of Chinese disseminated intravascular coagulation scoring system (version 2017) in patients with acute promyelocytic leukemia].
    Huang YT; Liu XF; Fu RF; Chen YF; Liu W; Xue F; Zhang L; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):480-484. PubMed ID: 30032565
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance Evaluation of Five Different Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Predicting Mortality in Patients with Complicated Sepsis.
    Ha SO; Park SH; Hong SB; Jang S
    J Korean Med Sci; 2016 Nov; 31(11):1838-1845. PubMed ID: 27709865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis and of the Japanese Ministry of Health and Welfare for overt DIC.
    Wada H; Gabazza EC; Asakura H; Koike K; Okamoto K; Maruyama I; Shiku H; Nobori T
    Am J Hematol; 2003 Sep; 74(1):17-22. PubMed ID: 12949885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
    Testa U; Lo-Coco F
    Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of modified non-overt DIC criteria on the prediction of poor outcome in patients with sepsis.
    Oh D; Jang MJ; Lee SJ; Chong SY; Kang MS; Wada H
    Thromb Res; 2010 Jul; 126(1):18-23. PubMed ID: 20079919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
    Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
    Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia.
    Li S; Gao Y; Li F; Zheng Y; Su Y
    Ann Hematol; 2023 Apr; 102(4):787-794. PubMed ID: 36750485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
    Kario K; Matsuo T; Kodama K; Katayama S; Kobayashi H
    Thromb Res; 1992 May; 66(4):435-44. PubMed ID: 1412208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated intravascular coagulation (DIC) diagnosed based on the Japanese Association for Acute Medicine criteria is a dependent continuum to overt DIC in patients with sepsis.
    Gando S; Saitoh D; Ogura H; Mayumi T; Koseki K; Ikeda T; Ishikura H; Iba T; Ueyama M; Eguchi Y; Otomo Y; Okamoto K; Kushimoto S; Endo S; Shimazaki S;
    Thromb Res; 2009 Mar; 123(5):715-8. PubMed ID: 18774163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels.
    Egi M; Morimatsu H; Wiedermann CJ; Tani M; Kanazawa T; Suzuki S; Matsusaki T; Shimizu K; Toda Y; Iwasaki T; Morita K
    Thromb Haemost; 2009 Apr; 101(4):696-705. PubMed ID: 19350114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated intravascular coagulation score evolution in 48 h predicts early death in acute promyelocytic leukemia patients.
    Infante JB; Esteves GV; Raposo J; de Lacerda JF
    Eur J Haematol; 2024 May; 112(5):840-844. PubMed ID: 38305491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.
    Ikezoe T; Takeuchi A; Isaka M; Arakawa Y; Iwabu N; Kin T; Anabuki K; Sakai M; Taniguchi A; Togitani K; Yokoyama A
    Leuk Res; 2012 Nov; 36(11):1398-402. PubMed ID: 22917769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.